Lymphomas
(MO40597) A MULTICENTRIC, OPEN-LABEL, SINGLE ARM STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA (PHASE IV STUDY)
- Details
ClinicalTrials.gov ID:
NCT03817853
Diagnosis Type:
NA
USOR Number:
- Address
,
P: